The Texas Medical Institute of Technology (TMIT) is very proud to support the Scholars Program as one of the Pay-It-Forward initiatives that it is funding. In fact, we owe the Institute for Healthcare Improvement (IHI) for creating the environment that allowed TMIT to germinate the development of our Pay-It-Forward program principles that will ground all of TMIT's future philanthropy.
The terrific improvement impact that TMIT witnessed as IHI faculty through the Medication Management Idealized Design effort, the ICU Idealized Design effort, and the Quantum collaboratives was inspiring. Recognizing that all of the faculty were getting more speaking requests than could possibly be met, the TMIT team realized how a combined gift of funds and multimedia assets could be put to great use by IHI, and at the same time allow TMIT to fulfill its own mission - to have the greatest possible patient impact as measured by the six IOM aims.
Gail Nielsen is the Patient Safety Administrator for the Iowa Health System, and currently a George W. Merck Fellow at the Institute for Healthcare Improvement (IHI). In this position she is responsible for a 10-hospital collaborative patient safety improvement effort that is changing culture to improve patient safety and spreading successful interventions across system hospitals. She is also the System's improvement advisor for IHS' collaboration efforts in conjunction with the IMPACT Network: Patient Safety, Flow Through Acute Care, and Office Practice and Outpatient Settings. She is the Collaborative Director of the System's Falls Prevention Collaborative. Mrs. Nielsen is a Safety Scholar for IHI and Project Manager for IHI's Quantum Leaps Community on Falls. She is a member of the Workgroup for the CDC Grant supported Iowa Patient Safety Demonstration Project. In the Spring of 2004, Mrs. Nielsen was named a Merck Scholar at the IHI and the Harvard School of Public Health. She is a faculty member at the IHI and speaks nationally on patient safety issues.
John Whittington, M.D. is the Coordinator for Clinical Effectiveness and Clinical Informatics and the Corporate Patient Safety Officer for the Order of Saint Francis Healthcare System (OSF). Part of his time is spent supporting various initiatives at the Institute for Healthcare Improvement (IHI) and co-leading the innovation community that is focused on mortality reduction. In his role as the Patient Safety Officer, Dr. Whittington facilitates change processes and system improvements that impact patient safety across the entire health system. He is a Faculty Member for IHI in Patient Safety, is an active member of the Illinois Hospital Association Patient Safety Committee, and is on the Board of Directors for the Sisters of Mercy Health System Quality Committee in St. Louis, MO.
Dr. Whittington is board certified in Family Practice medicine with a specialization in occupational medicine. He has spoken numerous times at national and local conferences regarding medication reconciliation, strategies for spreading improvement, failure mode effects analysis, engaging physicians, surgical site infections, failure to communicate, transforming healthcare, and many other topics.
Lee Vanderpool is Vice President at Dominican Hospital, Santa Cruz. He has 20 years of experience in healthcare administration, with a concentrated focus in leadership, clinical and ancillary operations, and continuous performance improvement. Mr. Vanderpool has chaired the hospital's Performance Improvement Linkage and Oversight Team (PILOT) since it's inception in 1992. This group assures continuous improvement through a structure that allows people to step away from the delivery of care to improve the way in which care is delivered. In addition, he is now the Chair of Dominican Hospital's Performance Improvement Council and is the architect for the hospital's leadership and performance improvement system.
Mr. Vanderpool has been a senior examiner for the California Governor's Golden State Quality Award Program, serving on both consensus and site visit examiner teams, and is currently an examiner with the Malcolm Baldrige National Quality Program. He has been a member of health care redesign collaborative through the Institute for Healthcare Improvement (IHI).
He holds a master's degree in computer science and business administration. Prior to his 20 years in health care, he worked in the information technology field in other industries, including municipal government, petroleum, and university education.
Glenn Robbins is a Medical Staff Clinical Pharmacist at Dominican Hospital, Santa Cruz. He oversees Clinical Outcomes Management, Clinical Pathway Development, Drug Information and Utilization Review, and he serves as the Medical Staff/Pharmacy Liaison. He is a participant and leader of numerous clinical pharmacy and performance improvement activities at Dominican Hospital and Catholic Healthcare West (CHW). His current responsibilities include optimizing drug therapy, medication safety, and quality improvement for Dominican. Mr. Robbins is on the Physician Support Services Process Improvement Team, the Institutional Review Board, and the Pharmacy and Therapeutics Committee at Dominican Hospital. He also serves as Chair of the Clinical Pharmacy Council at CHW. In 1997, he was a team-member of Dominican Hospital's first IHI collaborative (Improving Physician Prescribing). In 1999, he was the second-place winner of the National Hospital Pharmacy Quality Award. And in 2002, he was the second-place winner of the CHW Quality Summit Award for excellence in process improvement, for the reduction in contrast-agent associated acute renal failure. Mr. Robbins received Bachelor's degrees in Psychology and Pharmacy, and completed his residency in Clinical Pharmacy.
J. Scott Parrish, M.D., is Chairman of the Department of Critical Care Medicine at the Naval Medical Center San Diego. He is also part of the Institute for Healthcare Improvement (IHI) IMPACT network team, is a Reviewer for the Critical Care Medicine journal, and is the Course Director for Fundamentals of Critical Care Support at the Naval Medical Center. Since July 1996, he has been an Investigator with Coccidioides immitis Registry NMC. In May 2000, he completed a two-year investigation on "A Multicenter, Prospective, Randomized, Controlled Pivotal Trial for Efficacy of Partial Liquid Ventilation (PLV) with Low and High Doses of Perflubron in Adult Patients with Acute Lung Injury" (Protocol LVAD-007-INT October 1998- May 2000). Dr. Parrish is Board Certified in Internal Medicine with subspecialties in Pulmonary Medicine and Critical Care Medicine. He is currently a practicing physician in the Division of Pulmonary Medicine, Department of Internal Medicine at the Naval Medical Center San Diego.
Kim Newell is the Clinical Nurse Specialist in the Critical Care Nursing Department at the Naval Medical Center San Diego. She is one of three officers selected to be in the Critical Care Nurse Training Working Group to revise the Navy's critical care nurse training program. She is the Administrator of the Critical Care Courses in which she annually administers eight critical care courses to more than 150 students. As a member of the Critical Care Collaborative for the Institute for Healthcare Improvement (IHI), she was part of a team selected to present at the Critical Care Collaborative Spring Plenary Session. Her storyboard was selected for presentation at the National Forum on Quality Improvement in Health Care, and she was selected as a Critical Care Scholar by the Texas Medical Institute of Technology (TMIT) and IHI. She is also Chairman of the Nursing Education Committee and the Publications Chair of the San Diego County Chapter of the American Association of Critical-Care Nurses (AACN). Ms. Newell holds a Masters of Science degree in Nursing.
Nancy Kimmel, R.Ph., is the Patient Safety Officer for Missouri Baptist Hospital. She is responsible for assessing the facility for risk and conducting a Failure Mode Effects Analysis and Root Cause Analysis based on the findings of the evaluation. She has been involved in teaching quality improvement tools and process improvement team leadership, along with the development of BJC Healthcare System educational programs for team leading and tool usage. Ms. Kimmel holds a BS in Pharmacy and has specialized training in pharmaco-economic research through the American Society for Health System Pharmacists (ASHP), advanced experimental training in conducting and using outcome studies, and extensive training in performance improvement tools and education. She currently holds an appointment as an Assistant Professor at the University of Missouri Kansas City School of Pharmacy, teaching medication safety and outcomes research. Ms. Kimmel is a frequent speaker on Patient Safety nationally and internationally, and is a faculty member for the Institute for Healthcare Improvement (IHI) in the Adverse Drug Event Collaborative. She is a member of the ASHP, International Society of Outcomes Research (ISPOR), Patient Safety Officers Society, and IHI IMPACT network.
Donald M. Berwick is the Administrator of the Centers for Medicare & Medicaid Services. He was previously President and Chief Executive Officer of the Institute for Healthcare Improvement (IHI). He also serves as Clinical Professor of Pediatrics and Health Care Policy in the Department of Pediatrics at the Harvard Medical School and Professor of Health Policy and Management at the Harvard School of Public Health.
Dr. Berwick is also a pediatrician, Adjunct Staff in the Department of Medicine at Boston's Children's Hospital, and a Consultant in Pediatrics at Massachusetts General Hospital.
Dr. Berwick was appointed by President Clinton to serve on the Advisory Commission on Consumer Protection and Quality in the Healthcare Industry in 1997 and 1998. A summa cum laude graduate of Harvard College, Dr. Berwick holds a Master of Public Policy degree from the John F. Kennedy School of Government and an MD cum laude from the Harvard Medical School. He is the author of numerous articles, and co-authored the books Curing Health Care: New Strategies for Quality Improvement; New Rules: Regulation, Markets and the Quality of American Health Care; and Escape Fire: Designs for the Future of Health Care.
Dr. Berwick was chair of the Health Services Research Review Study Section of the Agency for Health Care Policy and Research (AHCPR) from 1995-1999 and Chair of the National Advisory Council of the Agency for Healthcare Research and Quality (AHRQ) from 1999 through 2001. He was vice chair of the U.S. Preventive Services Task Force from 1990 through 1996. From 1996 through 1999, Dr. Berwick served as the first "Independent Member" of the Board of Trustees of the American Hospital Association (AHA). He also served from 1989 through 1991 as a member of the Panel of Judges for the Malcolm Baldrige National Quality Award program. He is a member of several editorial boards, including that of the BMJ. From 1987 through 1991, Dr. Berwick was co-founder and Co-Principal Investigator for the National Demonstration Project on Quality Improvement in Health Care (NDP). He is a past president of the International Society for Medical Decision-Making. He is an elected member of the Institute of Medicine (IOM) of the National Academy of Sciences, and since 2002, serves on the IOM's governing Council.
Carol Haraden, Ph.D., is a quality of care outcomes researcher, educator, and change leader. She has been a dean in higher education, a clinician, consultant, and researcher. Prior to joining the Institute for Healthcare Improvement (IHI), Carol was the Vice President for Quality Services at Fletcher Allen Health Care in Burlington, VT. Carol has written several grants, and served as the Measurement Consultant for a Robert Wood Johnson grant. Carol is a frequent speaker on program evaluation, measurement and quality improvement topics, and has authored a chapter in the American Hospital Association (AHA) publication, Work Redesign. She holds an adjunct appointment at the University of Vermont.
Institute for Healthcare Improvement
As Vice President of IHI, Dr. Haraden is responsible for patient safety and idealized design development in the areas of medication use, intensive care units, and the flow of patients through the health care system.
Roger Resar, M.D., was trained as a pulmonologist and intensivist. Boarded in Internal Medicine, Pulmonary, and Critical Care Medicine, he has 24 years of experience in a community hospital. Over the last several years, Dr. Resar has become a change agent for the Luther Midelfort - Mayo Health System and the Institute for Healthcare Improvement (IHI). He has been a contributor to the IHI redesign efforts in Patient Safety, Office Redesign, and Intensive Care Unit (ICU). He has recently become a Senior IHI Fellow.
Frances A. Griffin, RRT, MPA, is a Director at the Institute for Healthcare Improvement (IHI) in Cambridge, MA. Prior to joining IHI full time, Ms. Griffin worked at Meridian Health System in New Jersey, where she directed quality, case management, emergency preparedness, and several other departments at one of the hospitals. Ms. Griffin also previously served as the director of performance improvement at Morristown Memorial Hospital in New Jersey. Ms. Griffin's clinical background is as a Registered Respiratory Therapist and she holds a Master's Degree in Public Administration from Fairleigh Dickinson University. Ms. Griffin has been a member of the IHI Idealized Design of the Medication System team, attended the IHI Breakthrough Series College, and been a faculty member for IHI's Quantum Leaps Collaborative, Calls to Action, and other programs.
Dr. Frankel obtained his medical degree from Boston University and completed anesthesia training at Boston's Beth Israel and Children's hospitals. Dr. Frankel practiced as a general and cardiac anesthesiologist until 1990, and then moved to Newton-Wellesley Hospital in Newton, MA to work in a community anesthesia practice. In 1995, Dr. Frankel began to divide his time between anesthesia practice and promulgating medical safety concepts. As the Medical Safety Officer at the Newton-Wellesley Hospital, and currently as the Director for Patient Safety for Partners Healthcare System, an integrated delivery system of seven major hospitals in the Boston area, Dr. Frankel seeks to develop methods to practically incorporate patient safety concepts into the delivery of healthcare and has headed numerous initiatives at hospital and integrated delivery network levels. He is also on the faculty of the Institute for Healthcare Improvement (IHI) and has co-chaired two IHI Collaboratives on adverse drug events. Dr. Frankel is a member of and trustee of the Massachusetts Coalition for the Prevention of Medical Errors (MCPME). As a member of MCPME, he helped develop the Massachusetts Coalition Best Practice Recommendations for Medication Use. Dr. Frankel consults and speaks nationally on the topics of patient safety and medical error.
He has co-authored the following two papers:
Comunale ME, Frankel AS. Contaminated platelets as a cause of hemodynamic instability after cardiopulmonary bypass. J Cardiothorac Anesth. 1989 Apr;3(2):207-10.
Frankel AS, Holzman RS. Air embolism during posterior spinal fusion. Can J Anaesth. 1988 Sep;35(5):511-4.
Frank Federico, R.Ph., is a Director at the Institute for Healthcare Improvement (IHI) where his area of focus is patient safety. Prior to joining IHI, Mr. Federico was the Program Director of the Office Practice Evaluation Program and a Loss Prevention/Patient Safety Specialist at Risk Management Foundation of the Harvard Affiliated Institutions. He is one of the Executive Producers of "First Do No Harm, Part 2: Taking the Lead." While Mr. Federico was Director of Pharmacy at Children's Hospital Boston, he was co-chair of a quality improvement team charged with revamping the medication system and chaired the Adverse Drug Event Subcommittee. He has been affiliated with IHI since 1996 as a faculty member and co-chair of a number of IHI Adverse Drug Event Collaboratives.
Charles R. Denham, M.D.
Chairman, Texas Medical Institute of Technology (TMIT)
In parallel with a healthcare product development career of more than 20 years, Dr. Denham practiced medicine as a Radiation Oncologist for 12 years. A graduate of the University of Alberta, he undertook specialty training at the Baylor College of Medicine, with training at Texas Children's Hospital and the MD Anderson Tumor Institute at Texas Medical Center in Houston. He was an Associate Professor of Biomedical Engineering at the University of Texas in Austin from 1983 to 2002. He has also served as an instructor and innovation developer at a number of medical schools and business schools with focus on innovation adoption, technology transfer, and commercialization. His research has resulted in numerous product and process innovations in surgery, oncology, imaging, and ophthalmology. He has served on the editorial boards of journals as a technology application specialist and authored several works in basic science, managed care, and medication management and safety.
He is a founder and Chairman of the Texas Medical Institute of Technology (TMIT), a non-profit medical research organization dedicated to drive adoption of clinical solutions in patient safety and healthcare performance improvement. TMIT sponsors numerous projects in patient safety, including The Leapfrog Group's Safe Practices Leap, an initiative based on the National Quality Forum's 30 Safe Practices (May 2003), and which TMIT continues to lead with the help of numerous thought leaders and subject matter experts.
TMIT also collaborates with the Institute for Healthcare Improvement (IHI), for which Dr. Denham serves as a faculty member in the area of technology assessment and adoption. Through TMIT, the Community Emergency Healthcare Initiative (CEHI), a performance network development effort, has been developed for small rural and frontline community hospitals.
Dr. Denham is CEO of the HCC Corporation (HCC). Launched in 1983, HCC is a business development accelerator in medical, technical, and service product fields. It has led, developed, or supported more than 300 product development teams in more than 50 product categories including pharmaceuticals, devices, capital equipment, and software applications. Non-medical HCC efforts range from aerospace, e-commerce, fitness, and software to consumer health product categories. HCC is the developer of a care-centered, evidence-based Breakthrough Technology Processing System now used for product assessment and purchase by one-third of U.S. hospitals purchasing over $20 billion in products in 2002. HCC partners include numerous global healthcare supplier and high technology companies with more than $90 billion in revenues and more than 90% U.S. hospital market penetration.
TMIT and HCC have formal collaborative initiatives with federal agencies and associated organizations including National Aeronautics and Space Administration (NASA), the Institute of Medicine (IOM), Health Resources and Services Administration (HRSA), the Agency Healthcare Research and Quality (AHRQ), and the Department of Defense (DoD).
Powered by HCC's Information Power Grid System
SafetyLeaders®, CareMoms®, and SpeakerLink® are trademarks of HCC Corp., licensed to TMIT